Structure of the myotonic dystrophy type 2 RNA and designed small molecules that reduce toxicity.

Myotonic dystrophy type 2 (DM2) is an incurable neuromuscular disorder caused by a r(CCUG) expansion (r(CCUG)(exp)) that folds into an extended hairpin with periodically repeating 2×2 nucleotide internal loops (5'CCUG/3'GUCC). We designed multivalent compounds that improve DM2-associated defects using information about RNA-small molecule interactions. We also report the first crystal structure of r(CCUG) repeats refined to 2.35 Å. Structural analysis of the three 5'CCUG/3'GUCC repeat internal loops (L) reveals that the CU pairs in L1 are each stabilized by one hydrogen bond and a water-mediated hydrogen bond, while CU pairs in L2 and L3 are stabilized by two hydrogen bonds. Molecular dynamics (MD) simulations reveal that the CU pairs are dynamic and stabilized by Na(+) and water molecules. MD simulations of the binding of the small molecule to r(CCUG) repeats reveal that the lowest free energy binding mode occurs via the major groove, in which one C residue is unstacked and the cross-strand nucleotides are displaced. Moreover, we modeled the binding of our dimeric compound to two 5'CCUG/3'GUCC motifs, which shows that the scaffold on which the RNA-binding modules are displayed provides an optimal distance to span two adjacent loops.

[1]  M. Disney,et al.  Two-dimensional combinatorial screening enables the bottom-up design of a microRNA-10b inhibitor. , 2014, Chemical Communications.

[2]  Juan J. Marugan,et al.  Induction and Reversal of Myotonic Dystrophy Type 1 Pre-mRNA Splicing Defects by Small Molecules , 2013, Nature Communications.

[3]  J. Fransen,et al.  Design and Analysis of Effects of Triplet Repeat Oligonucleotides in Cell Models for Myotonic Dystrophy , 2013, Molecular therapy. Nucleic acids.

[4]  Two new drugs for homozygous familial hyperchelesterolemia. , 2013, The Medical letter on drugs and therapeutics.

[5]  Jessica L. Childs-Disney,et al.  Rational design of bioactive, modularly assembled aminoglycosides targeting the RNA that causes myotonic dystrophy type 1. , 2012, ACS chemical biology.

[6]  J. Berglund,et al.  Utilizing the GAAA tetraloop/receptor to facilitate crystal packing and determination of the structure of a CUG RNA helix. , 2012, Biochemistry.

[7]  Bruce M. Wentworth,et al.  Targeting nuclear RNA for in vivo correction of myotonic dystrophy , 2012, Nature.

[8]  T. Cooper,et al.  RNase H-mediated degradation of toxic RNA in myotonic dystrophy type 1 , 2012, Proceedings of the National Academy of Sciences.

[9]  M. Disney,et al.  Recent advances in developing small molecules targeting RNA. , 2012, ACS chemical biology.

[10]  A. Baranger,et al.  MBNL1–RNA Recognition: Contributions of MBNL1 Sequence and RNA Conformation , 2012, Chembiochem : a European journal of chemical biology.

[11]  G. van Ommen,et al.  Targeting Several CAG Expansion Diseases by a Single Antisense Oligonucleotide , 2011, PloS one.

[12]  M. Disney,et al.  Influencing uptake and localization of aminoglycoside-functionalized peptoids. , 2011, Molecular bioSystems.

[13]  A. Baranger,et al.  Selective inhibition of MBNL1–CCUG interaction by small molecules toward potential therapeutic agents for myotonic dystrophy type 2 (DM2)† , 2011, Nucleic acids research.

[14]  A. Laquérriere,et al.  Misregulated alternative splicing of BIN1 is associated with T tubule alterations and muscle weakness in myotonic dystrophy , 2011, Nature Medicine.

[15]  D. Lilley,et al.  Novel Ligands for a Purine Riboswitch Discovered by RNA-Ligand Docking , 2011, Chemistry & biology.

[16]  N. Greig,et al.  The alpha-synuclein 5′untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen , 2011, Journal of Neural Transmission.

[17]  Eric B. Roesch,et al.  Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat. , 2010, Biochemistry.

[18]  Harry A. Stern,et al.  Reparameterization of RNA χ Torsion Parameters for the AMBER Force Field and Comparison to NMR Spectra for Cytidine and Uridine , 2010, Journal of chemical theory and computation.

[19]  S. Richard,et al.  Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients , 2010, The EMBO journal.

[20]  Jessica L. Childs-Disney,et al.  The Role of Flexibility in the Rational Design of Modularly Assembled Ligands Targeting the RNAs that Cause the Myotonic Dystrophies , 2010, Chembiochem : a European journal of chemical biology.

[21]  Giulio Rastelli,et al.  Fast and accurate predictions of binding free energies using MM‐PBSA and MM‐GBSA , 2009, J. Comput. Chem..

[22]  G. Breningstall.  Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy , 2010 .

[23]  A. Baranger,et al.  A simple ligand that selectively targets CUG trinucleotide repeats and inhibits MBNL protein binding , 2009, Proceedings of the National Academy of Sciences.

[24]  B. Wieringa,et al.  Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy , 2009, Proceedings of the National Academy of Sciences.

[25]  J. H. Maddocks,et al.  Conformational analysis of nucleic acids revisited: Curves+ , 2009, Nucleic acids research.

[26]  Krzysztof Sobczak,et al.  Reversal of RNA Dominance by Displacement of Protein Sequestered on Triplet Repeat RNA , 2009, Science.

[27]  M. Disney,et al.  Rational and modular design of potent ligands targeting the RNA that causes myotonic dystrophy 2. , 2009, ACS chemical biology.

[28]  D. Patel,et al.  Structural insights into RNA recognition by the alternative-splicing regulator muscleblind-like MBNL1 , 2008, Nature Structural &Molecular Biology.

[29]  L. M. Alvarez-Salas,et al.  Nucleic acids as therapeutic agents. , 2008, Current topics in medicinal chemistry.

[30]  Matthew D Disney,et al.  Two-dimensional combinatorial screening identifies specific aminoglycoside-RNA internal loop partners. , 2008, Journal of the American Chemical Society.

[31]  T. Cheatham,et al.  Determination of Alkali and Halide Monovalent Ion Parameters for Use in Explicitly Solvated Biomolecular Simulations , 2008, The journal of physical chemistry. B.

[32]  Paul J Hergenrother,et al.  Targeting RNA with small molecules. , 2008, Chemical reviews.

[33]  Warf Mb,et al.  MBNL binds similar RNA structures in the CUG repeats of myotonic dystrophy and its pre-mRNA substrate cardiac troponin T , 2007 .

[34]  Matthew D Disney,et al.  A small molecule microarray platform to select RNA internal loop-ligand interactions. , 2007, ACS chemical biology.

[35]  J. Holton,et al.  Structural basis for aminoglycoside inhibition of bacterial ribosome recycling , 2007, Nature Structural &Molecular Biology.

[36]  J. Šponer,et al.  Refinement of the AMBER Force Field for Nucleic Acids: Improving the Description of α/γ Conformers , 2007 .

[37]  Jessica L. Childs-Disney,et al.  Using Selection to Identify and Chemical Microarray to Study the RNA Internal Loops Recognized by 6′‐N‐Acylated Kanamycin A , 2007, Chembiochem : a European journal of chemical biology.

[38]  Yaser Hashem,et al.  SwS: a solvation web service for nucleic acids , 2007, Bioinform..

[39]  Daniel Svozil,et al.  Refinement of the AMBER force field for nucleic acids: improving the description of alpha/gamma conformers. , 2007, Biophysical journal.

[40]  S. Gullans,et al.  Drug discovery targeted to the Alzheimer’s APP mRNA 5′-untranslated region , 2007, Journal of Molecular Neuroscience.

[41]  Jeremy S Logue,et al.  The structural basis of myotonic dystrophy from the crystal structure of CUG repeats. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Rangarajan Sampath,et al.  SAR by MS: discovery of a new class of RNA-binding small molecules for the hepatitis C virus: internal ribosome entry site IIA subdomain. , 2005, Journal of medicinal chemistry.

[43]  Eric Westhof,et al.  Crystal structures of complexes between aminoglycosides and decoding A site oligonucleotides: role of the number of rings and positive charges in the specific binding leading to miscoding , 2005, Nucleic acids research.

[44]  Y. Cho‐Chung,et al.  Killing the messenger: antisense DNA and siRNA. , 2004, Current drug targets.

[45]  R. Andino,et al.  Solution structure of a consensus stem-loop D RNA domain that plays important roles in regulating translation and replication in enteroviruses and rhinoviruses. , 2004, Biochemistry.

[46]  Junmei Wang,et al.  Development and testing of a general amber force field , 2004, J. Comput. Chem..

[47]  Randy J Read,et al.  Electronic Reprint Biological Crystallography Likelihood-enhanced Fast Rotation Functions Biological Crystallography Likelihood-enhanced Fast Rotation Functions , 2003 .

[48]  J. Wöhnert,et al.  The structure of the stemloop D subdomain of coxsackievirus B3 cloverleaf RNA and its interaction with the proteinase 3C. , 2004, Structure.

[49]  Randy J Read,et al.  Electronic Reprint Biological Crystallography Phenix: Building New Software for Automated Crystallographic Structure Determination Biological Crystallography Phenix: Building New Software for Automated Crystallographic Structure Determination , 2022 .

[50]  E. Westhof,et al.  X-ray crystal structures of antibiotic-RNA complexes , 2002 .

[51]  R. Griffey,et al.  SAR by MS: a ligand based technique for drug lead discovery against structured RNA targets. , 2002, Journal of medicinal chemistry.

[52]  E. Garvey,et al.  Small molecule modulators of HIV Rev/Rev response element interaction identified by random screening. , 2002, Antiviral research.

[53]  P. Harper,et al.  Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. , 2002, Human molecular genetics.

[54]  W. Delano.  The PyMOL Molecular Graphics System , 2002 .

[55]  Richard S Geary,et al.  Fomivirsen: clinical pharmacology and potential drug interactions. , 2002, Clinical pharmacokinetics.

[56]  M. Swanson,et al.  Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. , 2001, Human molecular genetics.

[57]  Nathan A. Baker,et al.  Electrostatics of nanosystems: Application to microtubules and the ribosome , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[58]  G. Varani,et al.  Targeting RNA with small-molecule drugs: therapeutic promise and chemical challenges. , 2001, Accounts of chemical research.

[59]  S. Naylor,et al.  Myotonic Dystrophy Type 2 Caused by a CCTG Expansion in Intron 1 of ZNF9 , 2001, Science.

[60]  J. Sühnel,et al.  Molecular Dynamics Simulation Reveals Conformational Switching of Water-Mediated Uracil-Cytosine Base Pairs in an RNA Duplex , 2022 .

[61]  Steven,et al.  SAR by MS , 2001 .

[62]  V. Ramakrishnan,et al.  Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics , 2000, Nature.

[63]  Y. Kyōgoku,et al.  Solution structure of an RNA duplex including a C-U base pair. , 2000, Biochemistry.

[64]  E. Westhof,et al.  Aminoglycoside-RNA interactions. , 1999, Current opinion in chemical biology.

[65]  D. Filman,et al.  Crystal structure of a brominated RNA helix with four mismatched base pairs: An investigation into RNA conformational variability. , 1999, Biochemistry.

[66]  J. Puglisi,et al.  Recognition of the codon-anticodon helix by ribosomal RNA. , 1999, Science.

[67]  A. Ferré-D’Amaré,et al.  A general module for RNA crystallization. , 1998, Journal of molecular biology.

[68]  E. Vivés,et al.  Pharmacokinetics of oligonucleotides in cell culture. , 1997, Ciba Foundation symposium.

[69]  O Kennard,et al.  Structure of a mispaired RNA double helix at 1.6-A resolution and implications for the prediction of RNA secondary structure. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[70]  I. Tinoco,et al.  Crystal structure of an RNA double helix incorporating a track of non-Watson–Crick base pairs , 1991, Nature.

[71]  Harry F. Noller,et al.  Interaction of antibiotics with functional sites in 16S ribosomal RNA , 1987, Nature.

[72]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[73]  Hilla Peretz,et al.  Ju n 20 03 Schrödinger ’ s Cat : The rules of engagement , 2003 .